Lifetree Clinical Research Expands Capacity

Lifetree Clinical Research has expanded its in-patient capacity from 60 to 75 beds in its early stage research unit in Salt Lake City, UT. The increase in beds will allow the company to conduct larger Phase I studies and support expansion into early stage research in new therapeutic areas such as experimental human models, Alzheimer’s disease, hepatitis C, and broadened neuropsychiatric capabilities.  

“Lifetree is recognized worldwide for our services in human abuse liability (HAL), and Lifetree’s ever-growing expertise in researching disorders of the Central Nervous System (CNS) and analgesia. Increasing demand for our early-stage services drove the need for expansion of our Clinical Pharmacology inpatient capacity from 60 to 75 beds,” said Alice Jackson, president of Lifetree Clinical Research.